$CLSH
CLS Holdings USA, Inc.

2015 Q1 Form 10-Q Financial Statement

#000119312515010665 Filed on January 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $340.0K $200.0K $20.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $340.0K $1.250K $20.00K
YoY Change -61.48%
Operating Profit -$340.0K -$1.250K -$20.00K
YoY Change -61.48%
Interest Expense $0.00 $242.00 $0.00
YoY Change 86.15%
% of Operating Profit
Other Income/Expense, Net -$242.00
YoY Change 86.15%
Pretax Income -$340.0K -$1.492K -$20.00K
YoY Change -55.79%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$340.0K -$1.492K -$20.00K
YoY Change -55.79%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$22.67K -$13.33K -$1.778K
COMMON SHARES
Basic Shares Outstanding 11.25M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $0.00 $11.38K
YoY Change
Accrued Expenses $0.00 $0.00 $3.750K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $10.00K $0.00 $30.49K
YoY Change 0.0% -100.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.00K $0.00 $30.49K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $10.00K $0.00 $30.00K
YoY Change 0.0% -100.0%
SHAREHOLDERS EQUITY
Retained Earnings -$56.81K -$48.76K
YoY Change
Common Stock $1.125K $1.125K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $0.00 $0.00 -$30.49K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q2
OPERATING ACTIVITIES
Net Income -$340.0K -$1.492K -$20.00K
YoY Change -55.79%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities $0.00 -$180.0K $0.00
YoY Change 1700.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$300.0K
YoY Change
Cash From Investing Activities $0.00 -$300.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 470.0K 0.000
YoY Change 4600.0%
NET CHANGE
Cash From Operating Activities 0.000 -180.0K 0.000
Cash From Investing Activities 0.000 -300.0K
Cash From Financing Activities 0.000 470.0K 0.000
Net Change In Cash 0.000 -10.00K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 -$180.0K $0.00
Capital Expenditures $0.00 $0.00
Free Cash Flow $0.00 -$180.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
2470
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-1395
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-2836
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11250000 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11250000 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
30488
CY2014Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5210
CY2014Q2 us-gaap Interest Payable Current
InterestPayableCurrent
371
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
1125
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11382
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48759
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3750
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-30488
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17146
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
100
CY2014Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
9675
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2014Q2 us-gaap Assets
Assets
0
CY2014Q2 us-gaap Assets Current
AssetsCurrent
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11250000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11250000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1125
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56812
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
0
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55687
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2014Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
56812
CY2014Q4 us-gaap Assets
Assets
0
CY2014Q4 us-gaap Cash
Cash
0
CY2014Q4 us-gaap Assets Current
AssetsCurrent
0
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11250000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-51367
us-gaap Gross Profit
GrossProfit
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-55367
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1445
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-56812
us-gaap Revenues
Revenues
0
us-gaap Net Income Loss
NetIncomeLoss
-56812
us-gaap Interest Paid
InterestPaid
0
us-gaap Interest Expense
InterestExpense
1445
us-gaap Operating Expenses
OperatingExpenses
55367
us-gaap Professional Fees
ProfessionalFees
40309
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5210
us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
558
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
51367
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3750
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
28057
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15058
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
250
us-gaap Notes Reduction
NotesReduction
37925
adsnd Imputed Interest Debt
ImputedInterestDebt
887
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8229
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11250000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
us-gaap Gross Profit
GrossProfit
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-8229
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-178
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8407
us-gaap Revenues
Revenues
0
us-gaap Net Income Loss
NetIncomeLoss
-8407
us-gaap Interest Paid
InterestPaid
0
us-gaap Interest Expense
InterestExpense
178
us-gaap Operating Expenses
OperatingExpenses
8229
us-gaap Professional Fees
ProfessionalFees
8139
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4999
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-10
us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
152
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8229
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3240
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90
adsnd Imputed Interest Debt
ImputedInterestDebt
26
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
CLS Holdings USA, Inc.
dei Trading Symbol
TradingSymbol
ADSND
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18382
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
187
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
18382
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
18382
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
650
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <u>Use of Estimates</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11250000 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-11-30
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1492
CY2014Q4 us-gaap Revenues
Revenues
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11132
us-gaap Notes Reduction
NotesReduction
37925
dei Entity Central Index Key
EntityCentralIndexKey
0001522222
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-1492
CY2014Q4 us-gaap Interest Expense
InterestExpense
242
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
1250
CY2014Q4 us-gaap Professional Fees
ProfessionalFees
1250
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Gross Profit
GrossProfit
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-7250
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-803
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8053
us-gaap Revenues
Revenues
0
us-gaap Net Income Loss
NetIncomeLoss
-8053
us-gaap Interest Paid
InterestPaid
0
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
456
us-gaap Interest Expense
InterestExpense
803
us-gaap Operating Expenses
OperatingExpenses
7250
us-gaap Professional Fees
ProfessionalFees
6600
adsnd Imputed Interest Debt
ImputedInterestDebt
616
adsnd Adjustments To Additional Paid In Capital Debt Forgiveness
AdjustmentsToAdditionalPaidInCapitalDebtForgiveness
37925
CY2011Q2 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.001
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-1441
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-27923
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
271
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-3865
CY2011Q2 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
18000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-15530
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11250000 shares
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2013Q4 us-gaap Gross Profit
GrossProfit
0
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3245
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-130
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3375
CY2013Q4 us-gaap Revenues
Revenues
0
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-3375
CY2013Q4 us-gaap Interest Expense
InterestExpense
130
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
3245
CY2013Q4 us-gaap Professional Fees
ProfessionalFees
3200
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11250000 shares
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q4 us-gaap Gross Profit
GrossProfit
0
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1250
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-242

Files In Submission

Name View Source Status
0001193125-15-010665-index-headers.html Edgar Link pending
0001193125-15-010665-index.html Edgar Link pending
0001193125-15-010665.txt Edgar Link pending
0001193125-15-010665-xbrl.zip Edgar Link pending
adsnd-20141130.xml Edgar Link completed
adsnd-20141130.xsd Edgar Link pending
adsnd-20141130_cal.xml Edgar Link unprocessable
adsnd-20141130_def.xml Edgar Link unprocessable
adsnd-20141130_lab.xml Edgar Link unprocessable
adsnd-20141130_pre.xml Edgar Link unprocessable
d843733d10q.htm Edgar Link pending
d843733dex311.htm Edgar Link pending
d843733dex312.htm Edgar Link pending
d843733dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending